LEU— AI Stock Forecast & Price Targets
Published 7/13/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live LEU price forecast →
Centrus Energy is a strategically scarce asset — the sole U.S.-licensed HALEU enricher with a finalized $1.07B DOE contract, $1.87B cash, and mechanical S&P SmallCap 600 demand starting July 14 — but trades at ~57x trailing / ~63x forward P/E while burning ~$58M/quarter in FCF into a binary Aug 4 earnings print. The $145-$210 range remains operative; without margin/FCF confirmation, this is a range-trade with squeeze optionality (23.2% short float, 18.9M float), not a compounder.
HOLD into the Aug 4 print — do not size a swing trade through a binary event with elevated IV. The operative range is $145-$210 with SMA50 (~$180) as the pivot. Tactical add trigger only on a reclaim of $180 with Rel Volume >1.5 (today's 0.72 kills any squeeze case); tactical trim into $200-$210 if it prints pre-earnings. Invalidation short-term: a break below $145 on volume redefines the range lower. Index inclusion (July 14) mechanical bid is a known event — fade strength that fails to break $210 within a week.
1-6 month view: HOLD, base case the stock oscillates within $150-$200 until the Aug 4 print either confirms Q1'26's 41.1% gross margin is repeatable and guides FCF stabilization (bull path toward $210+) or reveals margins reverted (bear path toward $145 and possibly through). Expected return range from $171: -15% to +25%. Key catalysts: (1) Aug 4 earnings — the arbiter; (2) Oklo LOI conversion to a firm offtake; (3) additional DOE task orders extending the contract stack. What changes my mind: two consecutive quarters of positive FCF plus a firm Oklo agreement would justify moving to ACCUMULATE with a higher base target; a sub-30% gross margin print with widening FCF loss would move this to TRIM.
1-3 year view: LEU is a genuine strategic option on the U.S. domestic nuclear fuel cycle rebuild — sole licensed HALEU enricher, DOE-funded runway, and demand tied to advanced reactor deployment (Oklo, X-energy, TerraPower). If HALEU commercial demand materializes on schedule and Piketon scales to nameplate, revenue could compound at 25%+ over 3 years and the current 63x forward multiple could compress into a defensible 25-30x on real earnings. Biggest structural risk: HALEU demand is tethered to advanced-reactor timelines that have a strong history of slipping, and Centrus's operating leverage cuts both ways — if utilization stays lumpy, ROIC stays sub-5% and the equity is dead money at these multiples. This is a name to own on evidence, not narrative.
Revenue is uneven and shrinking on a TTM basis (Sales Y/Y TTM -4.05%; TTM revenue $452.3M), with quarterly swings from $74.9M (Q3'25) to $154.5M (Q2'25) that betray heavy customer-timing lumpiness. Margin quality is similarly noisy — gross margin ranged from -5.7% (Q3'25) to +41.1% (Q1'26), with Q1'26's step-up the first credible bridge toward the forward multiple but not yet proven repeatable. The balance sheet is the clear strength: $1.87B cash vs $1.18B total debt = ~$690M net cash, current ratio 5.72, working capital $1.89B — a multi-year execution runway without dilution pressure. Cash flow is the honest weakness: two consecutive quarters of ~-$58M FCF (Q1'26 -$58.3M on $23.2M capex; Q4'25 -$58.0M), TTM operating CF -$20.6M, and capex ramping into Piketon. ROE of 12.25% flatters the picture; ROIC of 3.11% is the truer read on capital efficiency. EPS is deteriorating (Q/Q -72%, TTM Y/Y -48.5%) even as the P&L narrative improves — the valuation offers no execution cushion at 57x trailing / 63x forward.
Across timeframes the structure is a well-defined range against a longer-term downtrend. The 1wk chart shows the stock has round-tripped from the $380s peak into a $145-$210 zone, with SMA200 -29.6% confirming the primary trend is still down. The 4h/1d panels show price stabilizing above SMA20 (+0.59%) but below SMA50 (-5.34%) — a coiling, indecisive setup with RSI 49.25 (neutral). Support has repeatedly held near $145-$150 (52w low $144.65); resistance sits at $180-$185 (SMA50) and then the range top near $210. The model's own forecast bands are internally inconsistent: 1h/4h project $178-$228 with bullish_prob 1.00 on 1d (but its 1d realized directional accuracy is 49% vs 63% naive — below baseline, so discount heavily), while the 1wk forecast collapses to $66.91 with bullish_prob 0.00 — that disagreement is itself a signal of low model conviction on this name. Prior bull targets above $220 have systematically failed to print; anchor upside near the top of the established range, not extrapolated.
Signal: (1) The $900M DOE task order within a $1.07B enrichment contract is finalized, moving Piketon from demonstration to commercial-scale HALEU — a genuine strategic milestone confirmed via Item 1.01 8-K on July 2. (2) S&P SmallCap 600 inclusion effective July 14 creates a mechanical passive bid against an 18.9M float. (3) Sell-side is trimming targets even on good news — BofA cut $240→$205 (Neutral), Needham cut $314→$264 (Buy) — signaling the Street is de-risking multiples ahead of the Aug 4 print. Noise: retrospective 10-year performance pieces and a Simply Wall St. "71% undervalued" headline that leans on DCF assumptions the FCF profile does not currently support. The pattern is clear across recent months: narrative wins (DOE, index, Oklo LOI) have not translated into sustained upside without margin/FCF confirmation in the P&L. The Aug 4 print is the arbiter.
- Finalized $900M DOE task order within $1.07B enrichment agreement — moves Piketon from demonstration to commercial-scale HALEU production (July 2 8-K)
- S&P SmallCap 600 inclusion effective July 14 creates structural passive demand against an 18.9M float and 23.2% short interest
- Oklo LOI optionality — conversion to a firm, revenue-backed HALEU offtake would be the single highest-value re-rating catalyst
- Q1'26 gross margin step-up to 41.1% (vs -5.7% in Q3'25) — if repeatable in the Aug 4 print, it is the first credible bridge to the forward multiple
- $1.87B cash / $690M net cash / current ratio 5.72 funds multi-year Piketon capex without dilution risk
- Additional DOE task orders extending the contract stack beyond $1.07B as domestic enrichment policy accelerates
- Valuation: ~57x trailing / ~63x forward P/E against TTM EPS -48.5% and Q/Q EPS -72% leaves no execution cushion into the Aug 4 print
- FCF burn: two consecutive quarters at ~-$58M with Piketon capex stepping up ($23.2M in Q1'26 vs $3.6M in Q2'25)
- Gross margin lumpiness (-5.7% to +41.1% across four quarters) makes steady-state modeling unreliable; ROIC of 3.11% is the honest number
- Binary Aug 4 earnings with elevated IV; sell-side already de-risking (BofA $240→$205, Needham $314→$264)
- HALEU commercial demand depends on advanced-reactor timelines (Oklo, X-energy) that have historically slipped
- SMA200 -29.6% confirms the primary trend is still down; 100% retail bullish sentiment against a thin float amplifies downside on any negative surprise
- Model forecast unreliable on this name — 1d directional accuracy 49% vs 63% naive baseline, and internal 1d/1wk contradiction (bullish_prob 1.00 vs 0.00) signals low model conviction
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord